Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: Pharmacological implications

Pharmacogenetics

Volumn 7, Issue 6, 1997, Pages 485-495

  Ciotti, Marco ^b   Marrone, Aldo ^a   Potter, Christine ^b   Owens, Ida S ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Experimental drugs; Phenol UDP glucuronosyltransferase; PKa values; Polymorphism; Therapeutic drugs

Indexed keywords

1 NAPHTHOL; 3 O METHYLDOPA; 4 NITROPHENOL; 4 TERT BUTYLPHENOL; ACEBUTOLOL; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; DOPAMINE DERIVATIVE; GLUCURONOSYLTRANSFERASE; LABETALOL; METHYLDOPA; METOPROLOL; NADOLOL; PHENOL DERIVATIVE; PINDOLOL; PROPRANOLOL; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; TIMOLOL; UMBELLIFERONE;

ARTICLE; DRUG METABOLISM; GENETIC POLYMORPHISM; HUMAN; MUTATION; PRIORITY JOURNAL;

EID: 0030699360     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199712000-00007     Document Type: Article

References (27)

1. Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O. Identification of defects in the genes for bilirubin UDP-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 1993: 197, 1239-1244.
2. Arion WJ, Wallin BK, Carlson PW, Lange AJ. The specificity of glucose 6-phosphatase of liver microsomes. J Biol Chem 1972: 247, 2558-2565.
3. Arora HK, Aggarwal AR, Singh RP. Theoretical and experimental study of hydroxycoumarins. Ind J Chem 1981: 169, 168-169.
4. Bordwell FG, Zhang X-M. Acidities and homolytic bond dissociation enthalpies of 4-substituted-2, 6-di-tert-butylphenols. J Phys Org Chem 1995: 8, 529-535.
5. Burchell B, Coughtrie MWH. UDP-glucuronosyltransferases. Pharmacol Ther 1989, 43, 261-289.
6. Ciotti M, Owens IS. Evidence for overlapping active sites for 17α-ethynylestradiol and bilirubin in the human major bilirubin UDP-glucuronosyltransferase. Biochemistry 1996: 35, 10119-10124.
7. Ciotti M, Yeatman MT, Sokol RJ, Owens IS. Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar Type I patient. J Biol Chem 1995: 270, 3284-3291.
8. Dean J. In: Dean J, ed. Lange's Handbook of Chemistry. 13th edition. Analytical chemistry. New York: McGraw-Hill, 1985: 5-51.
9. de Morais SMF, Wells PG. Enhanced acetaminophen toxicity in rats with bilirubin glucuronyltransferase deficiency. Hepatology 1989: 10, 163-167.
10. Dutton GJ. Glucuronidation of Drugs and Other Compounds. Boca Raton, FL: The CRC Press, 1980.
11. Harding D, Fournel-Gigleux S, Jackson MR, Burchell B. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci USA 1988: 85, 8381-8385.
12. Haugland RP. In: Larison KD, ed. Handbook of fluorescent probes and research chemicals. 5th edition. 1992: 1992-1994.
13. Iyanagi T. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J Biol Chem 1991: 266, 24048-24052.
14. Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Roy Chowdhury N, Roy Chowdhury J, Munich A, Odièvre M. Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet 1994: 94, 693-697.
15. Mackenzie PI. The UDP-glucuronosyltransferase multigene family. In: Hodgson E, Philpot RM, eds. Reviews in biochemical toxicology. Raleigh NC: Toxicology Communications Inc, 1995: 11, 29-72.
16. Moghrabi N, Clarke DJ, Burchell B, Boxer M. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome Type I: implications in carrier detection and prenatal diagnosis. Am J Hum Genet 1993: 53, 722-729.
17. Ohmori HC, Ueda C, Nakagawa T, Nishiguchi S, Jeong J, Masui M. Unsymmetrical anodic C-C coupling of 2, 6-di-tert-butyl-4-methylphenol. Chem Pharm Bull 1986: 34, 508-515.
18. Owens IS, Ritter JK. Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog Nucl Acid Res Mol Biol 1995: 51, 305-338.
19. Ritter JK, Crawford JM, Owens IS. Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem 1991: 266, 1043-1047.
20. Ritter JK, Sheen YY, Owens IS. Cloning and expression of a human liver UDP-glucuronosyltransferase in COS-1 cells. 3, 4-catechol estrogens and estriol as primary substrates. J Biol Chem 1990: 265, 7900-7906.
21. Ritter JK, Yeatman MT, Ferriera P, Owens IS. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar Type I patient. J Clin Invest 1992: 90, 150-155.
22. Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens IS. A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar Type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem 1993: 268, 23573-23579.
23. Schultz TW, Cajina-Quezada M. Structure-activity relationships for mono alkylated or halogenated phenols. Toxicol Lett 1987: 37, 121-130.
24. Seppen J, Bosma PJ, Goldhoorn BG, Bakker CTM, Roy Chowdhury J, Roy Chowdhury N, Jansen PLM, Oude Elferink PJ. Discrimination between Crigler-Najjar Type I and II by expression of mutant bilirubin UDP-glucuronosyltransferase. J Clin Invest 1994: 268, 2385-2391.
25. Thigpen AE, Davis DL, Milatovich A, Mendonca BB. Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. Molecular genetics of steroid 5-α reductase 2 deficiency. J Clin Invest 1992: 90, 799-809.
26. Ueda H, Pereira-Rosario R, Riley CM, Perrin JH. Some pharmaceutical applications of diode array spectrophotometers. Drug Dev Indust Pharm 1985: 11, 833-843.
27. Wahbi AM, El-Yazbi FA, Barary MH, Sabri SM. Application of orthogonal functions to spectrophotometric analysis. Determination of dissociation constants. Intern J Pharmaceut 1993: 92, 15-21.